366 related articles for article (PubMed ID: 15180344)
1. Transdermal iontophoresis of rotigotine across human stratum corneum in vitro: influence of pH and NaCl concentration.
Nugroho AK; Li GL; Danhof M; Bouwstra JA
Pharm Res; 2004 May; 21(5):844-50. PubMed ID: 15180344
[TBL] [Abstract][Full Text] [Related]
2. Transdermal iontophoresis of rotigotine: influence of concentration, temperature and current density in human skin in vitro.
Nugroho AK; Li G; Grossklaus A; Danhof M; Bouwstra JA
J Control Release; 2004 Apr; 96(1):159-67. PubMed ID: 15063038
[TBL] [Abstract][Full Text] [Related]
3. Compartmental modeling of transdermal iontophoretic transport: I. In vitro model derivation and application.
Nugroho AK; Della Pasqua O; Danhof M; Bouwstra JA
Pharm Res; 2004 Nov; 21(11):1974-84. PubMed ID: 15587918
[TBL] [Abstract][Full Text] [Related]
4. Comparing different salt forms of rotigotine to improve transdermal iontophoretic delivery.
Ackaert OW; Eikelenboom J; Wolff HM; Bouwstra JA
Eur J Pharm Biopharm; 2010 Feb; 74(2):304-10. PubMed ID: 19969079
[TBL] [Abstract][Full Text] [Related]
5. Transdermal iontophoresis of the dopamine agonist 5-OH-DPAT in human skin in vitro.
Nugroho AK; Li L; Dijkstra D; Wikström H; Danhof M; Bouwstra JA
J Control Release; 2005 Mar; 103(2):393-403. PubMed ID: 15763622
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic studies of the transdermal iontophoretic delivery of 5-OH-DPAT in vitro.
Ackaert OW; Van Smeden J; De Graan J; Dijkstra D; Danhof M; Bouwstra JA
J Pharm Sci; 2010 Jan; 99(1):275-85. PubMed ID: 19718740
[TBL] [Abstract][Full Text] [Related]
7. Lontophoretic delivery of apomorphine in vitro: physicochemic considerations.
Li GL; Danhof M; Bouwstra JA
Pharm Res; 2001 Nov; 18(11):1509-13. PubMed ID: 11758756
[TBL] [Abstract][Full Text] [Related]
8. An update on pharmacological, pharmacokinetic properties and drug-drug interactions of rotigotine transdermal system in Parkinson's disease and restless legs syndrome.
Elshoff JP; Cawello W; Andreas JO; Mathy FX; Braun M
Drugs; 2015 Apr; 75(5):487-501. PubMed ID: 25795100
[TBL] [Abstract][Full Text] [Related]
9. Iontophoretic delivery of apomorphine. I: In vitro optimization and validation.
van der Geest R; Danhof M; Boddé HE
Pharm Res; 1997 Dec; 14(12):1798-803. PubMed ID: 9453071
[TBL] [Abstract][Full Text] [Related]
10. Effect of pH on Iontophoretic Transport of Pramipexole Dihydrochloride across Human Epidermal Membrane.
Saepang K; Li SK; Chantasart D
Pharm Res; 2021 Apr; 38(4):657-668. PubMed ID: 33826056
[TBL] [Abstract][Full Text] [Related]
11. Steady-state plasma concentration profile of transdermal rotigotine: an integrated analysis of three, open-label, randomized, phase I multiple dose studies.
Elshoff JP; Braun M; Andreas JO; Middle M; Cawello W
Clin Ther; 2012 Apr; 34(4):966-78. PubMed ID: 22401642
[TBL] [Abstract][Full Text] [Related]
12. Transdermal iontophoretic delivery of selegiline hydrochloride, in vitro.
Kolli CS; Chadha G; Xiao J; Parsons DL; Babu RJ
J Drug Target; 2010 Nov; 18(9):657-64. PubMed ID: 20038213
[TBL] [Abstract][Full Text] [Related]
13. Iontophoretic enhancement of timolol across human dermatomed skin in vitro.
Fatouros DG; Bouwstra JA
J Drug Target; 2004 Jan; 12(1):19-24. PubMed ID: 15203908
[TBL] [Abstract][Full Text] [Related]
14. Validation and testing of a new iontophoretic continuous flow through transport cell.
van der Geest R; Danhof M; Boddé HE
J Control Release; 1998 Jan; 51(1):85-91. PubMed ID: 9685906
[TBL] [Abstract][Full Text] [Related]
15. Transdermal iontophoretic delivery of a novel series of dopamine agonists in vitro: physicochemical considerations.
Ackaert OW; De Graan J; Capancioni R; Dijkstra D; Danhof M; Bouwstra JA
J Pharm Pharmacol; 2010 Jun; 62(6):709-20. PubMed ID: 20636858
[TBL] [Abstract][Full Text] [Related]
16. Convective solvent flow across the skin during iontophoresis.
Kim A; Green PG; Rao G; Guy RH
Pharm Res; 1993 Sep; 10(9):1315-20. PubMed ID: 8234169
[TBL] [Abstract][Full Text] [Related]
17. Transdermal administration of radiolabelled [14C]rotigotine by a patch formulation: a mass balance trial.
Cawello W; Wolff HM; Meuling WJ; Horstmann R; Braun M
Clin Pharmacokinet; 2007; 46(10):851-7. PubMed ID: 17854234
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics, safety and tolerability of rotigotine transdermal patch in healthy Japanese and Caucasian subjects.
Cawello W; Kim SR; Braun M; Elshoff JP; Ikeda J; Funaki T
Clin Drug Investig; 2014 Feb; 34(2):95-105. PubMed ID: 24178238
[TBL] [Abstract][Full Text] [Related]
19. Iontophoretic transdermal delivery of sumatriptan: effect of current density and ionic strength.
Femenía-Font A; Balaguer-Fernández C; Merino V; López-Castellano A
J Pharm Sci; 2005 Oct; 94(10):2183-6. PubMed ID: 16136550
[TBL] [Abstract][Full Text] [Related]
20. Role of appendages in skin resistance and iontophoretic peptide flux: human versus snake skin.
Craane-van Hinsberg WH; Verhoef JC; Bax LJ; Junginger HE; Boddé HE
Pharm Res; 1995 Oct; 12(10):1506-12. PubMed ID: 8584490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
